Skip to main content
. 2023 Aug 18;64(9):558–565. doi: 10.3349/ymj.2023.0143

Table 3. Reasons for Enrolling Patients in the SCM Program.

Total (n=525) Passive SCM (n=205) Active SCM (n=320) p value*
Reasons for SCM 0.699
Infection 179 (50.7) 63 (50.4) 116 (50.9)
Changes in BP 10 (2.8) 6 (4.8) 4 (1.8)
Changes in HR/rhythm 5 (1.4) 1 (0.8) 4 (1.8)
Respiratory sx/sn 17 (4.8) 6 (4.8) 11 (4.8)
AKI with electrolyte imbalance 57 (16.1) 23 (18.4) 34 (14.9)
GI & hepatobiliary sx/sn 18 (5.1) 4 (3.2) 14 (6.1)
Allergic sx/sn 6 (1.7) 2 (1.6) 4 (1.8)
Opinions in cancer w/u & supportive care 6 (1.7) 1 (0.8) 5 (2.2)
Endocrinologic care including BSL control 5 (1.4) 2 (1.6) 3 (1.3)
Neurologic sx/sn 6 (1.7) 2 (1.6) 4 (1.8)
Hematologic conditions 12 (3.4) 5 (4.0) 7 (3.1)
Joint sx/sn 1 (0.3) 0 (0) 1 (0.4)
Pain management 5 (1.4) 0 (0) 5 (2.2)
Perioperative medical care 17 (4.8) 5 (4.0) 12 (5.3)
Sx/sn suggesting HF & MI 6 (1.7) 3 (2.4) 3 (1.3)
Others 3 (0.8) 2 (1.6) 1 (0.4)
More than one reason for SCM 172 (32.8) 80 (39.0) 92 (28.8) 0.014

AKI, acute kidney injury; BSL, blood sugar level; BP, blood pressure; GI, gastrointestinal; HR, heart rate; HF, heart failure; MI, myocardial infarction; SCM, surgical co-management; sx/sn, symptoms and signs; w/u, work up.

Data are presented as numbers (%).

*Significant differences between passive and active SCM patients were tested using the chi-square or Fisher’s exact test.